Investigation of the Binary System of Proxyphylline Enantiomers: Structural Resolution and Phase Diagram Determination - Normandie Université Accéder directement au contenu
Article Dans Une Revue Molecular Pharmaceutics Année : 2023

Investigation of the Binary System of Proxyphylline Enantiomers: Structural Resolution and Phase Diagram Determination

Résumé

The solid-state landscape of proxyphylline (PXL), a chiral derivative of theophylline crystallizing as a racemic compound, was extensively investigated by means of thermal analyses and diffraction techniques. This study revealed the presence of five distinct polymorphic forms that were characterized: two polymorphs of the racemic mixture and three polymorphs of the pure enantiomer. The nature of each solid phase was confirmed by combining the different analytical techniques, revealing the presence of a thermodynamically stable racemic compound, RI (TFus= 134 °C), in equilibrium with the stable enantiopure crystal form, EI (TFus = 148.3 °C). Additionally, other crystal forms could be evidenced: a polymorph of the racemic compound, RII (TFus= 111.5 °C), as well as two metastable conglomerates, cEI and cEII, and two other polymorphs of the pure enantiomer, EII and EIII. The crystal structures of RI and EI are reported and discussed, highlighting the diversity of molecular conformations that can be adopted by the PXL molecule, which accounts for the versatility of the crystallization behaviors observed in this system. These findings enhance our understanding of the crystallization behavior of chiral pharmaceutical compounds and have implications for optimizing their crystallization processes in the pharmaceutical industry.
Fichier non déposé

Dates et versions

hal-04369083 , version 1 (02-01-2024)

Identifiants

Citer

Clément Pinetre, Lina C Harfouche, Clément Brandel, El-Eulmi Bendeif, Morgane Sanselme, et al.. Investigation of the Binary System of Proxyphylline Enantiomers: Structural Resolution and Phase Diagram Determination. Molecular Pharmaceutics, 2023, ⟨10.1021/acs.molpharmaceut.3c00922⟩. ⟨hal-04369083⟩
27 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More